NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ... The Daily Astorian: Recent Controlled Study Validates the Significantly Lower Hemolysis of the SHA Whisper Device over Impella CP SALT LAKE CITY, /PRNewswire/ — In a transformative recent study, the Second Heart Assist Inc. Whisper™ device, a next-generation percutaneous mechanical circulatory support (pMCS) ...
Recent Controlled Study Validates the Significantly Lower Hemolysis of the SHA Whisper Device over Impella CP Business Wire: First Patients in the World Treated with Impella RP Flex with SmartAssist DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for ... First Patients in the World Treated with Impella RP Flex with SmartAssist Abiomed has recalled the labeling for catheters used in its Impella RP Flex with Smart Assist System, the US Food and Drug Administration announced Thursday. The action comes from concern over a lack ...
